Edwards Lifesciences Other Non-Current Liabilities 2010-2024 | EW
Edwards Lifesciences other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Edwards Lifesciences other non-current liabilities for the quarter ending June 30, 2024 were $0.676B, a 8.63% decline year-over-year.
- Edwards Lifesciences other non-current liabilities for 2023 were $0.778B, a 2.41% decline from 2022.
- Edwards Lifesciences other non-current liabilities for 2022 were $0.798B, a 17.74% decline from 2021.
- Edwards Lifesciences other non-current liabilities for 2021 were $0.97B, a 11.95% decline from 2020.
| Edwards Lifesciences Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $778 |
| 2022 | $798 |
| 2021 | $970 |
| 2020 | $1,101 |
| 2019 | $784 |
| 2018 | $713 |
| 2017 | $852 |
| 2016 | $536 |
| 2015 | $480 |
| 2014 | $307 |
| 2013 | $227 |
| 2012 | $206 |
| 2011 | $157 |
| 2010 | $121 |
| 2009 | $77 |
| Edwards Lifesciences Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $676 |
| 2024-03-31 | $765 |
| 2023-12-31 | $761 |
| 2023-09-30 | $738 |
| 2023-06-30 | $740 |
| 2023-03-31 | $845 |
| 2022-12-31 | $798 |
| 2022-09-30 | $839 |
| 2022-06-30 | $853 |
| 2022-03-31 | $961 |
| 2021-12-31 | $970 |
| 2021-09-30 | $993 |
| 2021-06-30 | $984 |
| 2021-03-31 | $1,094 |
| 2020-12-31 | $1,101 |
| 2020-09-30 | $1,078 |
| 2020-06-30 | $1,051 |
| 2020-03-31 | $778 |
| 2019-12-31 | $784 |
| 2019-09-30 | $729 |
| 2019-06-30 | $732 |
| 2019-03-31 | $732 |
| 2018-12-31 | $713 |
| 2018-09-30 | $742 |
| 2018-06-30 | $482 |
| 2018-03-31 | $809 |
| 2017-12-31 | $852 |
| 2017-09-30 | $557 |
| 2017-06-30 | $620 |
| 2017-03-31 | $605 |
| 2016-12-31 | $536 |
| 2016-09-30 | $514 |
| 2016-06-30 | $500 |
| 2016-03-31 | $494 |
| 2015-12-31 | $480 |
| 2015-09-30 | $318 |
| 2015-06-30 | $274 |
| 2015-03-31 | $267 |
| 2014-12-31 | $307 |
| 2014-09-30 | $282 |
| 2014-06-30 | $273 |
| 2014-03-31 | $229 |
| 2013-12-31 | $227 |
| 2013-09-30 | $226 |
| 2013-06-30 | $218 |
| 2013-03-31 | $212 |
| 2012-12-31 | $206 |
| 2012-09-30 | $186 |
| 2012-06-30 | $171 |
| 2012-03-31 | $169 |
| 2011-12-31 | $157 |
| 2011-09-30 | $151 |
| 2011-06-30 | $129 |
| 2011-03-31 | $128 |
| 2010-12-31 | $121 |
| 2010-09-30 | $110 |
| 2010-06-30 | $99 |
| 2010-03-31 | $81 |
| 2009-12-31 | $77 |
| 2009-09-30 | $113 |
| 2009-06-30 | $103 |
| 2009-03-31 | $92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $40.680B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.063B | 27.94 |
| Intuitive Surgical (ISRG) | United States | $171.313B | 97.00 |
| Alcon (ALC) | Switzerland | $47.672B | 33.56 |
| IQVIA Holdings (IQV) | United States | $44.239B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $42.083B | 50.62 |
| DexCom (DXCM) | United States | $27.834B | 39.69 |
| STERIS (STE) | Ireland | $23.508B | 27.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.781B | 0.00 |
| Waters (WAT) | United States | $19.789B | 29.50 |
| Hologic (HOLX) | United States | $18.981B | 20.64 |
| Sysmex ADR (SSMXY) | Japan | $12.317B | 38.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.224B | 13.70 |
| Teleflex (TFX) | United States | $11.380B | 17.69 |
| Globus Medical (GMED) | United States | $9.423B | 26.36 |
| Penumbra (PEN) | United States | $7.597B | 78.86 |
| Glaukos (GKOS) | United States | $6.721B | 0.00 |
| Masimo (MASI) | United States | $6.081B | 32.57 |
| TransMedics (TMDX) | United States | $5.203B | 222.80 |
| PROCEPT BioRobotics (PRCT) | United States | $4.309B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.304B | 25.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.791B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.773B | 16.26 |
| Veracyte (VCYT) | United States | $2.593B | 160.76 |
| Inari Medical (NARI) | United States | $2.586B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.562B | 20.88 |
| Nihon Kohden (NHNKY) | Japan | $2.508B | 15.61 |
| RxSight (RXST) | United States | $2.003B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.360B | 6.19 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.130B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.112B | 19.84 |
| Artivion (AORT) | United States | $1.046B | 96.04 |
| Alphatec Holdings (ATEC) | United States | $0.864B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.728B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 17.23 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.638B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.616B | 0.00 |
| IRadimed (IRMD) | United States | $0.614B | 33.19 |
| Paragon 28 (FNA) | United States | $0.581B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.341B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.327B | 9.98 |
| ClearPoint Neuro (CLPT) | United States | $0.322B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.306B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.251B | 0.00 |
| Nevro (NVRO) | United States | $0.217B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.173B | 12.15 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.128B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.099B | 14.81 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.035B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| Lifeward (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |